Clinical Trials Browser

Interventional × Carcinoma × Trabectedin × Clear all

NCT00050440 2013-01-08

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Phase 2 Completed

Carcinoma, Neoplasms, Uterine Neoplasms, Endometrial Neoplasms